177 related articles for article (PubMed ID: 31189175)
1. Brain Volume-Related Polymorphisms of the Glycogen Synthase Kinase-3β Gene and Their Effect on Antidepressant Treatment in Major Depressive Disorder.
Sunada N; Takekita Y; Nonen S; Wakeno M; Koshikawa Y; Ogata H; Kinoshita T; Kato M
Neuropsychobiology; 2019; 78(3):136-144. PubMed ID: 31189175
[TBL] [Abstract][Full Text] [Related]
2. Association of GSK3beta polymorphisms with brain structural changes in major depressive disorder.
Inkster B; Nichols TE; Saemann PG; Auer DP; Holsboer F; Muglia P; Matthews PM
Arch Gen Psychiatry; 2009 Jul; 66(7):721-8. PubMed ID: 19581563
[TBL] [Abstract][Full Text] [Related]
3. Possible association of the GSK3β gene with the anxiety symptoms of major depressive disorder and P300 waveform.
Liu S; Sun N; Xu Y; Yang C; Ren Y; Liu Z; Cao X; Sun Y; Xu Q; Zhang K; Shen Y
Genet Test Mol Biomarkers; 2012 Dec; 16(12):1382-9. PubMed ID: 23030648
[TBL] [Abstract][Full Text] [Related]
4. Interactions Between Glycogen Synthase Kinase-3β Gene Polymorphisms, Negative Life Events, and Susceptibility to Major Depressive Disorder in a Chinese Population.
Yang J; Ke S; Qiao Z; Yang X; Qiu X; Song X; Zhao E; Zhou J; Zhao M; Yang Y; Fang D; Cao D
Front Psychiatry; 2020; 11():503477. PubMed ID: 33658947
[No Abstract] [Full Text] [Related]
5. Association between glycogen synthase kinase-3beta gene polymorphisms and major depression and suicidal behavior in a Korean population.
Yoon HK; Kim YK
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):331-4. PubMed ID: 20015462
[TBL] [Abstract][Full Text] [Related]
6. Glycogen synthase kinase-3β genetic polymorphisms and insomnia in depressed patients: A prospective study.
Costemale-Lacoste JF; Colle R; Martin S; Asmar KE; Loeb E; Feve B; Verstuyft C; Trabado S; Ferreri F; Haffen E; Polosan M; Becquemont L; Corruble E
J Affect Disord; 2018 Nov; 240():230-236. PubMed ID: 30081294
[TBL] [Abstract][Full Text] [Related]
7. Association of the TLR4 gene with depressive symptoms and antidepressant efficacy in major depressive disorder.
Wang J; Yang C; Liu Z; Li X; Liu M; Wang Y; Zhang K; Sun N
Neurosci Lett; 2020 Sep; 736():135292. PubMed ID: 32763359
[TBL] [Abstract][Full Text] [Related]
8. Glycogen synthase kinase-3beta gene is associated with antidepressant treatment response in Chinese major depressive disorder.
Tsai SJ; Liou YJ; Hong CJ; Yu YW; Chen TJ
Pharmacogenomics J; 2008 Dec; 8(6):384-90. PubMed ID: 18195729
[TBL] [Abstract][Full Text] [Related]
9. Genetic association analysis of functional polymorphisms in neuronal nitric oxide synthase 1 gene (NOS1) and mood disorders and fluvoxamine response in major depressive disorder in the Japanese population.
Okumura T; Kishi T; Okochi T; Ikeda M; Kitajima T; Yamanouchi Y; Kinoshita Y; Kawashima K; Tsunoka T; Inada T; Ozaki N; Iwata N
Neuropsychobiology; 2010; 61(2):57-63. PubMed ID: 20016223
[TBL] [Abstract][Full Text] [Related]
10. A combined study of GSK3β polymorphisms and brain network topological metrics in major depressive disorder.
Liu Z; Guo H; Cao X; Cheng C; Yang C; Xu C; Zhang A; Sun N; Li X; Zhang K
Psychiatry Res; 2014 Sep; 223(3):210-7. PubMed ID: 24994693
[TBL] [Abstract][Full Text] [Related]
11. Glycogen synthase kinase 3β gene polymorphisms may be associated with bipolar I disorder and the therapeutic response to lithium.
Lin YF; Huang MC; Liu HC
J Affect Disord; 2013 May; 147(1-3):401-6. PubMed ID: 23021822
[TBL] [Abstract][Full Text] [Related]
12. 5-HT2A gene variants influence specific and different aspects of antidepressant response in Japanese and Italian mood disorder patients.
Kato M; Zanardi R; Rossini D; De Ronchi D; Okugawa G; Kinoshita T; Colombo C; Serretti A
Psychiatry Res; 2009 May; 167(1-2):97-105. PubMed ID: 19361869
[TBL] [Abstract][Full Text] [Related]
13. The interactive effects of genetic polymorphisms within LFA-1/ICAM-1/GSK-3β pathway and environmental hazards on the development of Graves' opthalmopathy.
Yang G; Fu Y; Lu X; Wang M; Dong H; Li Q
Exp Eye Res; 2018 Sep; 174():161-172. PubMed ID: 29800560
[TBL] [Abstract][Full Text] [Related]
14. CYP1A2 genetic polymorphisms are associated with treatment response to the antidepressant paroxetine.
Lin KM; Tsou HH; Tsai IJ; Hsiao MC; Hsiao CF; Liu CY; Shen WW; Tang HS; Fang CK; Wu CS; Lu SC; Kuo HW; Liu SC; Chan HW; Hsu YT; Tian JN; Liu YL
Pharmacogenomics; 2010 Nov; 11(11):1535-43. PubMed ID: 21121774
[TBL] [Abstract][Full Text] [Related]
15. Orphan nuclear receptor Rev-erb alpha gene (NR1D1) and fluvoxamine response in major depressive disorder in the Japanese population.
Kishi T; Kitajima T; Ikeda M; Yamanouchi Y; Kinoshita Y; Kawashima K; Okochi T; Ozaki N; Iwata N
Neuropsychobiology; 2009; 59(4):234-8. PubMed ID: 19571598
[TBL] [Abstract][Full Text] [Related]
16. Genetic variants in combination with early partial improvement as a clinical utility predictor of treatment outcome in major depressive disorder: the result of two pooled RCTs.
Kato M; Serretti A; Nonen S; Takekita Y; Wakeno M; Azuma J; Kinoshita T
Transl Psychiatry; 2015 Feb; 5(2):e513. PubMed ID: 25710119
[TBL] [Abstract][Full Text] [Related]
17. The Gender-Specific Interaction of
Ke S; Li J; Zhao L; Yang J; Zhao X; Zhang W; Qiu X; Yang X; Zhou J; Tong Y; Zhu X; Liu X; Yang Y; Qiao Z; Bu T
Oxid Med Cell Longev; 2022; 2022():2633127. PubMed ID: 35126809
[TBL] [Abstract][Full Text] [Related]
18. Sequence variations of ABCB1, SLC6A2, SLC6A3, SLC6A4, CREB1, CRHR1 and NTRK2: association with major depression and antidepressant response in Mexican-Americans.
Dong C; Wong ML; Licinio J
Mol Psychiatry; 2009 Dec; 14(12):1105-18. PubMed ID: 19844206
[TBL] [Abstract][Full Text] [Related]
19. Unravelling the GSK3β-related genotypic interaction network influencing hippocampal volume in recurrent major depressive disorder.
Inkster B; Simmons A; Cole JH; Schoof E; Linding R; Nichols T; Muglia P; Holsboer F; Sämann PG; McGuffin P; Fu CHY; Miskowiak K; Matthews PM; Zai G; Nicodemus K
Psychiatr Genet; 2018 Oct; 28(5):77-84. PubMed ID: 30080747
[TBL] [Abstract][Full Text] [Related]
20. Harm avoidance involved in mediating the association between nerve growth factor (NGF) gene polymorphisms and antidepressant efficacy in patients with major depressive disorder.
Yeh YW; Kuo SC; Chen CY; Liang CS; Ho PS; Yen CH; Chen TY; Shyu JF; Wan FJ; Lu RB; Huang SY
J Affect Disord; 2015 Sep; 183():187-94. PubMed ID: 26021968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
